Skip to main content
Clinical Trials/NCT05546736
NCT05546736
Not yet recruiting
Not Applicable

Effects of the iCanWork Intervention to Improve Cancer Survivors' Experience With Return to Work: A Randomized Controlled Trial (RCT)

McGill University1 site in 1 country270 target enrollmentApril 1, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cancer-related Problem/Condition
Sponsor
McGill University
Enrollment
270
Locations
1
Primary Endpoint
Change from baseline return to work status in the course of the 24-month study
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

The aim of this study is to evaluate the effectiveness of the iCanWork intervention in assisting cancer survivors (CS) to return to work (RTW) and its impact on their health-related quality of life (QoL), health service utilization, RTW readiness, time to RTW, and work capacity.

Detailed Description

The iCanWork intervention comprises several elements related to health and work, taken from the latest reviews that recommend a remote and individual intervention, led by a vocational rehabilitation counsellor (VRC), experts in assisting RTW for CS. The intervention includes 6 sessions with a VRC and 1-4 sessions with an occupational therapist (OT). A total of 270 CS will be recruited into 2 groups (intervention or control). The duration of this study is 24 months. Study participants will complete electronic questionnaires measuring study variables at baseline before randomization and at 6-month, 12-month, 18-month, and 24-month follow-ups.

Registry
clinicaltrials.gov
Start Date
April 1, 2023
End Date
September 1, 2026
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Christine Maheu

Associate Professor

McGill University

Eligibility Criteria

Inclusion Criteria

  • diagnosed with cancer (all types) treated with curative intent and of working age (between 18 and 65 at the time of diagnosis)
  • gainfully employed at the time of diagnosis (full or part-time, including students)
  • still on sick leave, including long-term disability leave, but for less than 2 years
  • has not started to return to work, since stopping due to cancer
  • can read and understand English or French
  • reside in Canada.

Exclusion Criteria

  • If the cancer survivor's physicians consider returning to work unwise, such as due to a metastatic cancer diagnosis

Outcomes

Primary Outcomes

Change from baseline return to work status in the course of the 24-month study

Time Frame: baseline, 6 months, 12 months, 18 months, 24 months

binary variable (Yes/No)

Secondary Outcomes

  • Change from baseline work capacity in the course of the 24-month study(baseline, 6 months, 12 months, 18 months, 24 months)
  • Change from baseline health related quality of life in the course of the 24-month study(baseline, 6 months, 12 months, 18 months, 24 months)
  • Change from baseline readiness to return to work in the course of the 24-month study(baseline, 6 months, 12 months, 18 months, 24 months)

Study Sites (1)

Loading locations...

Similar Trials